Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neuroendocrine Tumors × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 40 Breast Neoplasms 37 Prostatic Neoplasms 24 Colorectal Neoplasms 24 Lung Neoplasms 22 Pancreatic Neoplasms 13 Motor Activity 11 Carcinoma, Non-Small-Cell Lung 11 Hematologic Neoplasms 9 Head and Neck Neoplasms 9 Urinary Bladder Neoplasms 8 Neoplasm Metastasis 8 Anxiety Disorders 8 Stomach Neoplasms 7 Ovarian Neoplasms 7 Multiple Myeloma 6 Hematopoietic and Lymphatic System Neoplasm 6 Uterine Cervical Neoplasms 5 Radiodermatitis 5 Esophageal Neoplasms 5 Advanced Cancer 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Sarcoma 4 Rectal Neoplasms 4 Melanoma 4 Gastrointestinal Neoplasms 4 Carcinoma, Renal Cell 4 Breast Carcinoma In Situ 4 Anatomic Stage I Breast Cancer AJCC v8 4

Interventions

lutetium Lu 177 dotatate 2 Lutetium-177 2 Liquid Biopsy 2 pentetreotide 1 fluorodopa F 18 1 copper dotatate CU-64 1 Yttrium-90 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Single Photon Emission Computed Tomography Computed Tomography 1 Resveratrol 1 Respiratory Therapy 1 Referral and Consultation 1 Quality of Life 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Palliative Care 1 Nutrition Assessment 1 Needles 1 Magnetic Resonance Spectroscopy 1 Endoscopic Mucosal Resection 1 Diet Therapy 1 Data Collection 1 Cryosurgery 1 Control Groups 1 Colectomy 1 Betaine 1 90Y-octreotide, DOTA-Tyr(3)- 1 3-Iodobenzylguanidine 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02472678 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡